Pharmafile Logo
Pharmafocus logo
Advanced Search
body scan

Pfizer in metabolic disease push

September 11, 2015
Medical Communications, Research and Development AMRA, Pfizer, UK Biobank, med tech, metabolic disease, obesity

Pfizer has signed a research collaboration with a global medical health technology company, to investigate risk factors for metabolic conditions.  …

News
zs-pharma-logo_cmyk

Actelion confirms takeover talks with ZS Pharma

September 11, 2015
Research and Development, Sales and Marketing Actelion, Shire, ZS Pharma, mergers and acquisitions

Swiss drugmaker Actelion has entered discussions with US biotech company ZS Pharma, over a takeover thought to be worth $2.5 …

News
lyrica

High Court rules against Pfizer in Lyrica patent case

September 10, 2015
Medical Communications, Sales and Marketing Actavis, Lyrica, Pfizer, anxiety, epilepsy, generics, neuropathic pain, pregabalin

The High Court of England and Wales today ruled against Pfizer in the patent battle with Actavis on Pfizer’s blockbuster …

News
john_jeans

EM Imaging appoints new chairman

September 10, 2015
Manufacturing and Production, Research and Development EM Imaging, Optometry, ophthalmology

The board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans as non-executive …

Appointment
heart_rate_monitor_app

Featured market report: Healthcare mobility solutions market by products and services, global forecast to 2020

September 10, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing apps, healthcare mobility, market report, mobile healthcare, smartphones

The global healthcare mobility solutions market is set to grow by as much as 30% to 2020, as the healthcare …

Feature
lung cancer x ray

Lung cancer market to hit $10.9bn by 2021

September 10, 2015
Sales and Marketing AZD9291, GBI Research, GlobalData, NSCLC, industry analysis, industry intelligence, industry reports, keytruda, market intelligence lung cancer, market reports, market trends, non small cell lung cancer, non-small cell lung cancer, opdivo, world conference on lung cancer

The global market value for non-small cell lung cancer treatment will rise from $6.9 billion in 2014 to $10.9 billion …

News
Mylan building

Mylan to relaunch $27.1bn hostile takeover of Perrigo

September 10, 2015
Sales and Marketing Mylan Perrigo, acquisitions, hostile bid, mergers, takeover

Mylan is to make yet another hostile $27.1 billion bid for Irish over the counter drug manufacturer Perrigo on Monday, …

News
Truvada pill

Gilead’s Truvada prevents HIV infections in high-risk men

September 10, 2015
Research and Development Gilead, HIV, PrEP, Truvada, pre-exposure prophylaxis treatment, sexually transmitted infections

UK researchers say Truvada, Gilead’s HIV prevention treatment, should be added to the country’s ‘HIV prevention toolkit’, after a study …

News

GSK begins work on £100m India facility

September 9, 2015
Manufacturing and Production GlaxoSmithKline, India, manufacturing

GSK has begun work on its new Rs. 1000 crore (£100m) pharmaceutical factory in Vemgal, southern India. When fully operational …

News
Westminster

Pharma leaders urge UK Government not to cut spending

September 9, 2015
Research and Development Autumn spending review, George Osborne, R&D, government, research, research and development, research funding

Representatives of more than 200 life sciences organisations have urged the UK government to protect the sector from spending cuts. …

News
Alzheimer's research

Neurimmune kicks off late-stage Alzheimer’s study

September 9, 2015
Research and Development Alzheimer's disease, Biogen, Neurimmune, aducanumab, neurology

Neurimmune and its development partner Biogen are beginning a Phase III study of the companies’ potential Alzheimer’s treatment aducanumab.  The …

News
asthma inhalers

GSK suffers Breo late-stage trial blow

September 9, 2015
Research and Development COPD, GSK, Revlar, asthma, breo, clinical trial, phase III

GSK has hit a setback in its plans to expand sales of its blockbuster asthma treatment Breo, after a major …

News
michael_koslowski_picture

Mission Therapeutics appoints new chief medical officer

September 9, 2015
Medical Communications, Research and Development Dr Michael Koslowski, Mission Therapeutics

Mission Therapeutics has announced the appointment of Dr Michael Koslowski as chief medical officer. Dr Koslowski brings over 15 years’ …

Appointment
unisa_research_building

Yabao Pharmaceutical and UniSA embark on joint venture

September 9, 2015
Research and Development Cancer, Yabao Pharmaceutical

Yabao Pharmaceutical and the University of South Australia (UniSA) have joined together in a collaboration to develop new treatments for …

News

Biocair International Ltd achieves AEO approval

September 8, 2015
Medical Communications Biocair

We are pleased to announce that as of 8th September 2015 Biocair International Ltd is an Authorised Economic Operator (AEO). …

News
Press release

Sun Pharma strengthens opiates business

September 8, 2015
Manufacturing and Production Australia, GSK, Sun Pharma, manufacturing and production, opiates

Sun Pharmaceutical Industries has strengthened its global opiates manufacturing business with the acquisition of two Australian manufacturing facilities from GlaxoSmithKline. …

News
avastin

New treatment option for ovarian cancer patients in Scotland

September 8, 2015
Medical Communications, Research and Development, Sales and Marketing Roche, Scotland, avastin, ovarian cancer

The Scottish Medicines Consortium (SMC) has approved the use of Avastin in combination with paclitaxel chemotherapy as a treatment for women …

News
Europe flag

EMA launches project to boost early patient access to drugs

September 8, 2015
Research and Development EMA, European Medicines Agency, MAPPs, adaptive pathways, drug development, market access

The EMA is launching an adaptive pathway project to bring new medicinal products to market in Europe.  The ADAPT SMART …

News
novo_nordisk_new_hillerod_facility

Novo Nordisk expands in Denmark

September 8, 2015
Manufacturing and Production, Research and Development Denmark, Novo Nordisk, haemophilia API

Novo Nordisk has announced that the company is investing 500 million Danish kroner (about £48.8 million) in a new 19,000 …

News
massachusetts_institute_of_technology_7194419730

Novo joins forces with MIT innovating drug devices

September 8, 2015
Manufacturing and Production, Research and Development Novo Nordisk

Novo Nordisk has initiated a research collaboration with the Langer Laboratory at the Massachusetts Institute of Technology for what is …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026